370 related articles for article (PubMed ID: 10676586)
1. Generic substitution for brand name antiepileptic drugs: a survey.
Guberman A; Corman C
Can J Neurol Sci; 2000 Feb; 27(1):37-43. PubMed ID: 10676586
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic equivalency of generic antiepileptic drugs: results of a survey.
Wilner AN
Epilepsy Behav; 2004 Dec; 5(6):995-8. PubMed ID: 15582850
[TBL] [Abstract][Full Text] [Related]
3. Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy.
Haskins LS; Tomaszewski KJ; Crawford P
Epilepsy Behav; 2005 Aug; 7(1):98-105. PubMed ID: 15961350
[TBL] [Abstract][Full Text] [Related]
4. [Use of generic anti-epilepsy drugs in France: survey of neurologists and review of the literature].
Biraben A; De Toffol B; Semah F; Rouaud T
Rev Neurol (Paris); 2007 Apr; 163(4):455-61. PubMed ID: 17452947
[TBL] [Abstract][Full Text] [Related]
5. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues.
Crawford P; Feely M; Guberman A; Kramer G
Seizure; 2006 Apr; 15(3):165-76. PubMed ID: 16504545
[TBL] [Abstract][Full Text] [Related]
6. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
[TBL] [Abstract][Full Text] [Related]
7. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
Holtkamp M; Theodore WH
Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
[TBL] [Abstract][Full Text] [Related]
8. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ
Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000
[TBL] [Abstract][Full Text] [Related]
9. Prescribing generic antiepileptic drugs: Issues and concerns for nurse practitioners.
Barrett MW
J Am Acad Nurse Pract; 2010 Jun; 22(6):300-4. PubMed ID: 20536627
[TBL] [Abstract][Full Text] [Related]
10. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
[TBL] [Abstract][Full Text] [Related]
11. Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study.
Polard E; Nowak E; Happe A; Biraben A; Oger E;
Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1161-9. PubMed ID: 26395769
[TBL] [Abstract][Full Text] [Related]
12. Generic substitution of antiepileptic drugs.
Sander JW; Ryvlin P; Stefan H; Booth DR; Bauer J
Expert Rev Neurother; 2010 Dec; 10(12):1887-98. PubMed ID: 21091318
[TBL] [Abstract][Full Text] [Related]
13. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
Argumosa A; Herranz JL
Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
[TBL] [Abstract][Full Text] [Related]
14. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
[TBL] [Abstract][Full Text] [Related]
15. The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine.
Duh MS; Andermann F; Paradis PE; Weiner J; Manjunath R; Crémieux PY
Dis Manag; 2007 Aug; 10(4):216-25. PubMed ID: 17718660
[TBL] [Abstract][Full Text] [Related]
16. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
[TBL] [Abstract][Full Text] [Related]
17. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
Andermann F; Duh MS; Gosselin A; Paradis PE
Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
[TBL] [Abstract][Full Text] [Related]
18. Generic products of antiepileptic drugs (AEDs): is it an issue?
Bialer M
Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
[TBL] [Abstract][Full Text] [Related]
19. Understanding therapeutic equivalence in epilepsy.
Sankar R; Glauser TA
CNS Spectr; 2010 Feb; 15(2):112-23. PubMed ID: 20414156
[TBL] [Abstract][Full Text] [Related]
20. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]